BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 2650578)

  • 1. Acenocoumarol and pentoxifylline in intermittent claudication. A controlled clinical study. The APIC Study Group.
    Dettori AG; Pini M; Moratti A; Paolicelli M; Basevi P; Quintavalla R; Manotti C; Di Lecce C
    Angiology; 1989 Apr; 40(4 Pt 1):237-48. PubMed ID: 2650578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A controlled trial of pentoxifylline (Trental 400) in intermittent claudication: clinical, haemostatic and rheological effects.
    Reilly DT; Quinton DN; Barrie WW
    N Z Med J; 1987 Jul; 100(828):445-7. PubMed ID: 3330188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pentoxifylline (Trental)--a new drug for the treatment of peripheral chronic occlusive arterial disease.
    Chopra HK; Chopra KL; Aggarwal KK; Parashar SK
    J Med; 1988; 19(2):89-107. PubMed ID: 3049876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of intermittent claudication with pentoxifylline: a 12-month, randomized trial--walking distance and microcirculation.
    De Sanctis MT; Cesarone MR; Belcaro G; Nicolaides AN; Griffin M; Incandela L; Bucci M; Geroulakos G; Ramaswami G; Vasdekis S; Agus G; Bavera P; Ippolito E
    Angiology; 2002; 53 Suppl 1():S7-12. PubMed ID: 11865838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of intermittent claudication with pentoxifylline: meta-analysis of randomized controlled trials.
    Hood SC; Moher D; Barber GG
    CMAJ; 1996 Oct; 155(8):1053-9. PubMed ID: 8873633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Training by walking and drug therapy of peripheral arterial occlusive disease].
    Kiesewetter H; Blume J; Jung F; Gerhards M; Leipnitz G
    Vasa Suppl; 1987; 20():384-7. PubMed ID: 3321495
    [No Abstract]   [Full Text] [Related]  

  • 7. On the assessment of the efficacy of pentoxifylline (Trental).
    Rössner M; Müller R
    J Med; 1987; 18(1):1-15. PubMed ID: 3298515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of severe intermittent claudication with pentoxifylline: a 40-week, controlled, randomized trial.
    Cesarone MR; Belcaro G; Nicolaides AN; Griffin M; De Sanctis MT; Incandela L; Geroulakos G; Ramaswami G; Cazaubon M; Barsotti A; Vasdekis S; Bavera P; Ippolito E
    Angiology; 2002; 53 Suppl 1():S1-5. PubMed ID: 11865828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial of iloprost in patients with intermittent claudication.
    Creager MA; Pande RL; Hiatt WR
    Vasc Med; 2008 Feb; 13(1):5-13. PubMed ID: 18372433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of long-distance intermittent claudication with pentoxifylline: a 12-month, randomized trial.
    De Sanctis MT; Cesarone MR; Belcaro G; Nicolaides AN; Griffin M; Incandela L; Bucci M; Geroulakos G; Ramaswami G; Vasdekis S; Agus G; Bavera P; Ippolito E
    Angiology; 2002; 53 Suppl 1():S13-7. PubMed ID: 11865829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pentoxifylline--a new drug for the treatment of intermittent claudication.
    Chopra HK; Chopra KL; Aggarwal KK; Parashar SK
    Indian Heart J; 1989; 41(2):127-33. PubMed ID: 2744799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of pentoxifylline on severe intermittent claudication.
    Reich T; Gillings D
    Angiology; 1987 Sep; 38(9):651-6. PubMed ID: 3310744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral vasodilators versus pentoxifylline for the treatment of intermittent claudication.
    Aviado DM
    Ric Clin Lab; 1983; 13 Suppl 3():263-8. PubMed ID: 6143383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-range intermittent claudication and rest pain: microcirculatory effects of pentoxifylline in a randomized, controlled trial.
    Incandela L; De Sanctis MT; Cesarone MR; Belcaro G; Nicolaides AN; Geroulakos G; Ramaswami G
    Angiology; 2002; 53 Suppl 1():S27-30. PubMed ID: 11865832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous treatment of chronic peripheral occlusive arterial disease: a double-blind, placebo-controlled, randomized, multicenter trial of pentoxifylline.
    Rudofsky G; Haussler KF; Künkel HP; Schneider-May H; Spengel F; Symann O; Werner HJ
    Angiology; 1989 Jul; 40(7):639-49. PubMed ID: 2662830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intermittent claudication treated with pentoxifylline. A controlled trial].
    Skovborg F; Bonde-Petersen F; Bloch I; Christensen E
    Ugeskr Laeger; 1983 Nov; 145(47):3649-52. PubMed ID: 6362159
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pentoxifylline and intermittent claudication: critical analysis of clinical trials].
    Charansonney OL; Spriet A
    Therapie; 1995; 50(1):73-8. PubMed ID: 7754482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cilostazol: new drug. Intermittent claudication: too little efficacy, too many risks.
    Prescrire Int; 2009 Apr; 18(100):56-9. PubMed ID: 19585717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ticlopidine in the treatment of intermittent claudication: a 21-month double-blind trial.
    Balsano F; Coccheri S; Libretti A; Nenci GG; Catalano M; Fortunato G; Grasselli S; Violi F; Hellemans H; Vanhove P
    J Lab Clin Med; 1989 Jul; 114(1):84-91. PubMed ID: 2661700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic treatment of intermittent claudication.
    Porter JM; Bauer GM
    Surgery; 1982 Dec; 92(6):966-71. PubMed ID: 7147192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.